With head office in Stockholm, Sweden, our organisation now spans more than 30 countries, delivering treatments to patients in over 70 countries across the globe.
Reporting of adverse reactions
Patient safety is a priority for Sobi. We collect, analyse and react to any new information about the benefits and risks of our products. If you have information about a side effect or adverse reaction associated with any of our products, please let us know via [email protected].
Adverse reactions may also be reported to your national health authority as applicable according to national legislation.
Product complaints
Please contact [email protected].
Medical Information
Please contact your local Sobi office (please see list below) or [email protected].
Head office
Visiting address
Norra Stationsgatan 93A
Stockholm
Postal address
Swedish Orphan Biovitrum AB
SE-112 76 Stockholm
